Delayed Expansion of Murine BCR-ABL1+ Leukemia By Genetic and Pharmacological Inhibition of NOX2

Fredrik B Thoren , Lars Palmqvist , Malin Nilsson , Johan Gustafsson
Blood 130 2879 -2879

2017
Abstract PR010: Potentiating the efficacy of immune checkpoint blockade by targeting the epithelial-to-mesenchymal transition (EMT) in breast carcinomas

Mohammad Rashidian , Stefani Spranger , Elinor Ng Eaton , Anushka Dongre
Cancer immunology research 9

2021
Incidence and Severity of Covid-19 in Patients with and without Previously Verified Infections with Common Cold Coronaviruses.

Magnus Lindh , Johan Westin , Staffan Nilsson , Anna Martner
The Journal of Infectious Diseases 223 ( 10) 1831 -1832

1
2021
Impact of HLA-B Dimorphism in the Leader Peptide on Clinical Outcome in AML

Fredrik B Thoren , Johan Aurelius , Alexander Hallner , Frida E Sander
Blood 130 1425 -1425

2017
Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia.

Anna Martner , Fredrik B Thorén , Johan Aurelius , Jonas Söderholm
Expert Review of Hematology 3 ( 4) 381 -391

33
2010
NOX2-derived ROS in myeloid cell differentiation: Implications in cancer

Roberta Kiffin , Hanna Grauers Wiktorin , Kristoffer Hellstrand , Anna Martner
Free Radical Biology and Medicine 120

2018
Role of NOX2-Derived Reactive Oxygen Species in NK Cell–Mediated Control of Murine Melanoma Metastasis

Ebru Aydin , Junko Johansson , Faisal Hayat Nazir , Kristoffer Hellstrand
Cancer immunology research 5 ( 9) 804 -811

37
2017
Cytomegalovirus serostatus affects autoreactive NK cells and outcomes of IL2-based immunotherapy in acute myeloid leukemia

Elin Bernson , Alexander Hallner , Frida E. Sander , Malin Nicklasson
Cancer immunology research 6 ( 9) 1110 -1119

1
2018
Idelalisib Rescues Natural Killer Cells from Monocyte-Induced Immunosuppression by Inhibiting NOX2-Derived Reactive Oxygen Species

Ali A. Akhiani , Alexander Hallner , Roberta Kiffin , Ebru Aydin
Cancer immunology research 8 ( 12) 1532 -1541

3
2020
50
2012
The HLA-B -21 dimorphism impacts on NK cell education and clinical outcome of immunotherapy in acute myeloid leukemia.

Elin Bernson , Brwa Ali Hussein , Frida Ewald Sander , Mats Brune
Blood 133 ( 13) 1479 -1488

16
2019
22
2015
NOX2-dependent immunosuppression in chronic myelomonocytic leukemia.

Johan Aurelius , Alexander Hallner , Olle Werlenius , Rebecca Riise
Journal of Leukocyte Biology 102 ( 2) 459 -466

13
2017
Dynamics of myeloid cell populations during relapse-preventive immunotherapy in acute myeloid leukemia.

Anna Rydström , Alexander Hallner , Johan Aurelius , Frida Ewald Sander
Journal of Leukocyte Biology 102 ( 2) 467 -474

8
2017
Role of NOX2 for leukaemic expansion in a murine model of BCR‐ABL1+ leukaemia

Hanna Grauers Wiktorin , Tina Nilsson , Ebru Aydin , Kristoffer Hellstrand
British Journal of Haematology 182 ( 2) 290 -294

8
2018
NOX2 inhibition reduces oxidative stress and prolongs survival in murine KRAS-induced myeloproliferative disease.

Ebru Aydin , Alexander Hallner , Hanna Grauers Wiktorin , Anna Staffas
Oncogene 38 ( 9) 1534 -1543

11
2019
Immunotherapy with HDC/IL-2 may be clinically efficacious in acute myeloid leukemia of normal karyotype.

Malin S. Nilsson , Alexander Hallner , Mats Brune , Staffan Nilsson
Human Vaccines & Immunotherapeutics 16 ( 1) 109 -111

5
2020
Immunotherapy with histamine dihydrochloride and low-dose interleukin-2 favors sustained lymphocyte recovery in acute myeloid leukemia.

Alexander Hallner , Johan Aurelius , Fredrik Bergh Thorén , Frida Ewald Sander
European Journal of Haematology 94 ( 3) 279 -280

3
2015
Redox control of cancer cell destruction

Csaba Hegedűs , Katalin Kovács , Zsuzsanna Polgár , Zsolt Regdon
Redox Biology 16 59 -74

110
2018